NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) FCF Yield % : -7.91 (As of May. 22, 2024)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NewAmsterdam Pharma Co NV's Trailing 12-Month Free Cash Flow is $-141.24 Mil, and Market Cap is $1,752.92 Mil. Therefore, NewAmsterdam Pharma Co NV's FCF Yield % for today is -7.91%.

The historical rank and industry rank for NewAmsterdam Pharma Co NV's FCF Yield % or its related term are showing as below:

NAMS' s FCF Yield % Range Over the Past 10 Years
Min: -13.62 Med: 4.32 Max: 8.22
Current: -7.91

During the past 4 years, the highest FCF Yield % of NewAmsterdam Pharma Co NV was 8.22%. The lowest was -13.62%. And the median was 4.32%.

NAMS's FCF Yield % is ranked better than
61.83% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs NAMS: -7.91

NewAmsterdam Pharma Co NV's FCF Margin % for the quarter that ended in Dec. 2023 was -1,971.45%.

NewAmsterdam Pharma Co NV FCF Yield % Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV FCF Yield % Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

1.17

-15.33

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	12.84	-13.96	-15.83

Competitive Comparison of NewAmsterdam Pharma Co NV's FCF Yield %

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewAmsterdam Pharma Co NV's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's FCF Yield % falls into.

NewAmsterdam Pharma Co NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NewAmsterdam Pharma Co NV's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-141.242	/	921.187666
	=	-15.33%

NewAmsterdam Pharma Co NV's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-72.924	*	2	/	921.187666
	=	-15.83%

NewAmsterdam Pharma Co NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

NewAmsterdam Pharma Co NV FCF Yield % Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.